Search Within

Kaitlin Marie Woo

Formats
  1. Journal Article (55)
  2. Meeting Abstract (46)
Groups
  1. Department of Medicine (67)
  2. Biostatistics Service (57)
  3. Epidemiology and Biostatistics (57)
  4. Solid Tumor Oncology Division (54)
  5. Surgery (42)
  6. Department of Pathology and Laboratory Medicine (39)

More Groups

People
  1. Zhigang Zhang (30)
  2. Camelia Sima (23)
  3. Abraham Wu (19)
  4. Andreas Rimner (19)
  5. William Travis (17)
  6. Amanda Foster (16)

More People

Years
  1. 2019 (2)
  2. 2018 (4)
  3. 2017 (14)
  4. 2016 (29)
  5. 2015 (27)
  6. 2014 (25)
Publications
  1. Journal of Clinical Oncology (21)
  2. Journal of Thoracic Oncology (16)
  3. International Journal of Radiation Oncology, Biology, Physics (14)
  4. Blood (6)
  5. Annals of Oncology (3)
  6. Clinical Genitourinary Cancer (3)

More Publications

Publishers
  1. Elsevier Inc. (41)
  2. American Society of Clinical Oncology (22)
  3. Oxford University Press (7)
  4. American Society of Hematology (6)
  5. Elsevier Ireland Ltd. (3)
  6. John Wiley & Sons (3)

More Publishers

Results (101)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Predisposing factors for short stature in long-term survivors of high-risk neuroblastoma
    Meeting Abstract

    Yang, J. C.; Friedman, D. N.; Woo, K. M.; Kushner, B. H.; Cheung, N. K. V.; Modak, S.; Roberts, S. S.; Basu, E. M.; Wolden, S. L.
    International Journal of Radiation Oncology, Biology, Physics (2015)

    Fulltext@MSK | Save
  • Phase 2 trial of bortezomib in KRAS G12D mutant lung cancers
    Meeting Abstract

    Riely, G. J.; Litvak, A.; Rekhtman, N.; Pietanza, M. C.; Chaft, J. E.; Woo, K.; Paik, P.; Miller, V.; Kris, M. G.; Rodriguez, K.; more...
    Journal of Thoracic Oncology (2015)

    Fulltext@MSK | Save
  • Contemporary analysis of prognostic factors in patients with unresectable malignant pleural mesothelioma (MPM)
    Meeting Abstract

    Bille, A.; Zauderer, M.; Woo, K.; Rusch, V. W.; Krug, L. M.
    Journal of Thoracic Oncology (2015)

    Fulltext@MSK | Save
  • Diagnostic molecular testing in multiple lung cancers
    Meeting Abstract

    Naidoo, J.; Woo, K.; Sima, C. S.; Travis, W. D.; Arcila, M. E.; Finley, D. J.; Rusch, V.; Jones, D. R.; Kris, M. G.; Zauderer, M. G.
    Journal of Thoracic Oncology (2015)

    Fulltext@MSK | Save
  • T1a lung adenocarcinomas: Presence of spread of tumor through alveolar spaces (STAS), micropapillary and solid patterns determines outcomes
    Meeting Abstract

    Kadota, K.; Eguchi, T.; Rizk, N. P.; Woo, K. M.; Sima, C. S.; Park, B. J.; Jones, D. R.; Travis, W. D.; Adusumilli, P. S.
    Journal of Thoracic Oncology (2015)

    Fulltext@MSK | Save
  • Multiple lung cancers: Is their survival better or worse then other lung cancers?
    Meeting Abstract

    Naidoo, J.; Woo, K.; Sima, C. S.; Travis, W. D.; Arcila, M.; Finley, D. J.; Rusch, V. W.; Jones, D. R.; Kris, M. G.; Zauderer, M.
    Journal of Thoracic Oncology (2015)

    Fulltext@MSK | Save
  • Mesothelin and MUC16 (CA125) are antigen-targets for CAR T-cell therapy in primary and metastatic lung adenocarcinoma
    Meeting Abstract

    Eguchi, T.; Ujiie, H.; Morello, A.; Kadota, K.; Buitrago, D. H.; Woo, K.; Jones, D. R.; Travis, W. D.; Sadelain, M.; Adusumilli, P. S.
    Journal of Thoracic Oncology (2015)

    Fulltext@MSK | Save
  • Outcomes of primary refractory diffuse large B-cell lymphoma (DLBCL) treated with salvage chemotherapy and intention to transplant in the rituximab era
    Meeting Abstract

    Vardhana, S. A.; Moskowitz, C. H.; Sauter, C. S.; Matasar, M. J.; Galasso, N.; Woo, K. M.; Zhang, Z. G.
    Blood (2015)

    Fulltext@MSK | Save
  • TARC predicts PET-normalization and event free surival in relapsed/refractory Hodgkin lymphoma patients treated with brentuximab vedotin
    Meeting Abstract

    Moskowitz, A. J.; Cho, S.; Fleisher, M.; Woo, K. M.; Zhang, Z. G.; Fox, S.; McCall, S. J.; Schoder, H.; Yahalom, J.; Moskowitz, C. H.
    Blood (2015)

    Fulltext@MSK | Save
  • Hairy cell leukemia variant has similar survival to classical disease despite poorer responses to initial therapy: A 30-year experience from Memorial Sloan Kettering Cancer Center
    Meeting Abstract

    Getta, B.; Woo, K. M.; Devlin, S.; Park, J. H.; Abdel-Wahab, O.; Tallman, M. S.
    Blood (2015)

    Fulltext@MSK | Save